Levofloxacina Amperlem

Levofloxacin, the active ingredient in Levofloxacina Amperlem, is a fluoroquinolone antibiotic presented as an oral tablet for systemic use. It treats a range of bacterial infections in adults, including respiratory, urinary, and skin infections, by targeting susceptible pathogens.

GNH USA supplies Levofloxacina Amperlem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets across Europe, Asia and the Americas. This ensures product integrity from manufacture to delivery.

Levofloxacin is a fluoroquinolone antibiotic that acts on bacterial DNA replication, making it effective for several common infections.

- Community‑acquired pneumonia: eradicates susceptible respiratory pathogens and improves clinical outcomes. - Acute bacterial sinusitis: reduces sinus inflammation by eliminating causative bacteria. - Acute exacerbations of chronic bronchitis: shortens symptom duration and prevents complications. - Uncomplicated urinary tract infections: clears infection in the lower urinary tract. - Complicated urinary tract infections: treats infections involving renal parenchyma or structural abnormalities. - Skin and soft‑tissue infections: resolves bacterial cellulitis and wound infections.

Levofloxacin may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea: mild stomach upset occurring in many patients. - Diarrhea: loose stools that are usually self‑limiting. - Headache: transient cranial discomfort. - Rash: mild skin erythema or itching.

Serious or Rare Side Effects: - Tendon rupture: sudden tendon pain or rupture, especially of the Achilles. - QT interval prolongation: cardiac rhythm changes that may lead to arrhythmia. - Severe allergic reaction: anaphylaxis or angioedema requiring emergency care.

Before prescribing levofloxacin, clinicians should consider several safety precautions to minimize risk. - Assess renal function: adjust dose in patients with impaired clearance. - Avoid in patients with known tendon disorders: risk of tendonitis or rupture. - Monitor cardiac rhythm: caution when combined with other QT‑prolonging agents. - Use with caution in pregnancy: potential fetal risk is not well established. - Store at room temperature: keep in the original packaging, protect from moisture and heat.

Levofloxacin can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Antacids or iron supplements: metal cations bind the drug and markedly reduce absorption. - Warfarin: levofloxacin may potentiate anticoagulant effect, increasing bleeding risk. - Other QT‑prolonging drugs: combined use can precipitate serious cardiac arrhythmias.

Moderate Interactions (Monitor Closely): - NSAIDs: may increase risk of central nervous system stimulation. - Corticosteroids: concurrent use raises the chance of tendon injury. - Theophylline: levofloxacin can raise plasma theophylline levels, leading to toxicity.